Font Size:
![]()
Amgen to Pay $150 Million for Misdemeanor Charge of Misbranding Anemia Drug
The Litigation Daily
December 18, 2012
This article requires premium access
This article requires premium access to Connecticut Law Tribune. Please sign in or subscribe to read the full text.


